Ibrutinib Updates, Priority Reviews in Sarcoma and ALL, European Approval in Sarcoma, and More

Histologic Distinctions and Optimized Imaging Carve New Paths for Individualized PTCL Management

Subcutaneous Rituximab Remains Underutilized in Non-Hodgkin Lymphoma

Dr Seymour on the Role of Mutational Profiling in CLL

Liso-Cel Elicits Consistent Responses in R/R CLL/SLL, Irrespective of High-Risk Features